Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies, Clear Labs Ink Supply Agreement for Food Safety Testing

NEW YORK – Integrated DNA Technologies of Coralville, Iowa,said today that it has signed a multi-year agreement with Menlo Park, California-based Clear Labs to act as the primary supplier of next-generation sequencing oligo products for Clear Lab's NGS-based food safety platform

The firms believe the collaboration will help provide food producers with fast and high-quality food safety testing using IDT's oligo products.

According to Clear Labs, its Clear Safety platform allows users to detect food-based pathogens, including several strains of Listeria, as well as visualize contamination incidents on maps of food plants. 

"Our NGS products are often used to help research into complex diseases, such as cancer," Roman Terrill, senior VP at IDT, said in a statement. "Our oligos met all the requirements set out by Clear Labs for their innovative approach to NGS-based food safety." 

Financial details of the agreement were not disclosed. 

"Maintaining the accuracy of our testing platform is paramount, and so we have strict requirements for quality, quantity, speed, and performance from our supplier partners," Ramin Khaksar, senior VP of research and development at Clear Labs, said in a statement. "IDT meets all of our exacting needs and is able to fill our quantity requirements while delivering the necessary oligo-specific QC capabilities, [which] a something that array-based providers could not offer."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more